New treatments for early Alzheimer’s are bringing hope to thousands of patients and their families. The question is, who will get the treatment, how will the right patients be found in time, and will the healthcare system’s resources be sufficient? Life Science Sweden has spoken to Swedish researchers in Alzheimer’s who voice cautious hope but also see further challenges.
The estate settlement process is costly and time-consuming. Fintech startup Alix provides the world s first seamless wealth transfer platform, harnessing AI and humans.